Ectonucleotidases and nucleotide/nucleoside transporters as pharmacological targets for neurological disorders

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 6, 2012, Pages 739-750

  Bonan, Carla D ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Ecto 5' nucleotidase; Ectonucleotidases; Neurological disorders; Nucleoside transporters; Nucleoside triphosphate diphosphohydrolase; Nucleotide pyrophosphatase phosphodiesterase; Nucleotide transporters

Indexed keywords

4 AMINOBUTYRIC ACID; ABC TRANSPORTER A1; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; CARBAMAZEPINE; ECTO 5' NUCLEOTIDASE; ECTONUCLEOTIDASE; NUCLEOSIDE TRANSPORTER; NUCLEOTIDASE; NUCLEOTIDE PYROPHOSPHATASE; NUCLEOTIDE TRANSPORTER; PHENYTOIN; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG; VALPROIC ACID;

CELL ADHESION; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; EPILEPTOGENESIS; HUMAN; HYDROLYSIS; INTRACELLULAR TRANSPORT; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

5'-NUCLEOTIDASE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ANIMALS; BRAIN DISEASES; HUMANS; MOLECULAR TARGETED THERAPY; NUCLEOSIDE TRANSPORT PROTEINS; NUCLEOSIDE-TRIPHOSPHATASE; NUCLEOTIDASES; NUCLEOTIDE TRANSPORT PROTEINS; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; SIGNAL TRANSDUCTION;

EID: 84869038185     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712803581092     Document Type: Review

References (148)

1. Burnstock, G.; Krügel, U.; Abbracchio, M.P.; Illes, P. Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol., 2011, 95(2), 229-274.
2. Lazarowski, E.R.; Boucher, R.C.; Harden, T.K. Mechanisms of release of nucleotides and integration of their action as P2X-and P2Y-receptor activating molecules. Mol. Pharmacol., 2003, 64(4), 785-795.
3. Khakh, B.S.; Burnstock, G.; Kennedy, C.; King, B.F.; North, R.A.; Séguéla, P.; Voigt, M.;Humphrey, P.P. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev., 2001, 53(1), 107-118.
4. Abbracchio, M.P.; Burnstock, G.; Boeynaems, J.M.; Barnard, E.A.; Boyer, J.L.; Kennedy, C.; Knight, G.E.; Fumagalli, M.; Gachet, C.; Jacobson, K.A.; Weisman, G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev., 2006, 58(3), 281-341.
5. Yegutkin, G.G. Nucleotide-and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta, 2008, 1783(5), 673-694.
6. Schetinger, M.R.; Morsch, V.M.; Bonan, C.D.; Wyse; A.T. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors, 2007, 31(2), 77-98.
7. Kong, W.; Engel, K.; Wang, J. Mammalian nucleoside transporters. Curr. Drug Metab., 2004, 5(1), 63-84.
8. Fredholm, B.B.; IJzerman, A.P.; Jacobson, K.A.; Linden, J.; Müller, C.E. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol. Rev., 2011, 63(1), 1-34.
9. White, T.D. Direct detection of depolarisation-induced release of ATP from a synaptosomal preparation. Nature, 1977, 267(5606), 67-68.
10. Pankratov, Y.; Lalo, U.; Verkhratsky, A.; North, R.A. Vesicular release of ATP at central synapses. Pflugers Arch., 2006, 452(5), 589-597.
11. Bodin, P.; Burnstock, G. Purinergic signalling: ATP release. Neurochem. Res., 2001, 26, 959-969.
12. Sabirov, R.Z.; Okada, Y. ATP release via anion channels. Purinergic Signal., 2005, 1(4), 311-328.
13. Kim, W.S.; Bhatia, S.; Elliott, D.A.; Agholme, L.; Kågedal, K.; McCann, H.; Halliday, G.M.; Barnham, K.J.; Garner B. Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons. J. Alzheimers Dis., 2010, 21(1), 193-205.
14. Lazarowski, A.; Czornyj, L.; Lubienieki, F.; Girardi, E.; Vazquez, S.; D'Giano, C. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy. Epilepsia, 2007, 48(Suppl 5), 140-149.
15. Bell, P.D.; Lapointe, J.Y.; Sabirov, R.; Hayashi, S.; Peti-Peterdi, J.; Manabe, K.; Kovacs, G.; Okada, Y. Macula densa cell signaling involves ATP release through a maxi anion channel. Proc. Natl. Acad. Sci. USA, 2003, 100, 4322-4327.
16. Sabirov, R.Z.; Okada, Y. Wide nanoscopic pore of maxi-anion channel suits its function as an ATP-conductive pathway. Biophys. J., 2004, 87, 1672-1675.
17. Thompson, R.J.; Macvicar, B.A. Connexin and pannexin hemichannels of neurons and astrocytes. Channels (Austin), 2008, 2(2), 81-86.
18. Locovei, S.; Scemes, E.; Qiu, F.; Spray, D.C.; Dahl, G. Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex. FEBS Lett., 2007, 581, 483-488.
19. Pelegrin, P.; Surprenant, A. Pannexinα1 mediates large pore formation and interleukinα1B release by the ATPαgated P2X7 receptor. EMBO J., 2006, 25, 5071-5082.
20. Bargiotas, P.; Krenz, A.; Hormuzdi, S.G.; Ridder, D.A.; Herb, A.; Barakat, W.; Penuela, S.; von Engelhardt, J.; Monyer, H.; Schwaninger, M. Pannexins in ischemia-induced neurodegeneration. Proc. Natl. Acad. Sci. USA, 2011, 108(51), 20772-20777.
21. Orellana, J.A.; von Bernhardi, R.; Giaume, C.; Sáez, J.C. Glial hemichannels and their involvement in aging and neurodegenerative diseases. Rev. Neurosci., 2012, 23(2), 163-177.
22. Wang, X.; Arcuino, G.; Takano, T.; Lin, J.; Peng, W.G.; Wan, P.; Li, P.; Xu, Q.; Liu, Q.S.; Goldman, S.A.; Nedergaard, M. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med., 2004, 10(8), 821-827.
23. Ballerini, P.; Di Iorio, P.; Caciagli, F.; Rathbone, M.P.; Jiang, S.; Nargi, E.; Buccella, S.; Giuliani, P.; D'Alimonte, I.; Fischione, G;. Masciulli, A.; Romano, S.; Ciccarelli R. P2Y2 receptor upregulation induced by guanosine or UTP in rat brain cultured astrocytes. Int. J. Immunopathol. Pharmacol., 2006, 19(2), 293-308.
24. Goding, J.W.; Grobben, B.; Slegers, H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim. Biophys. Acta, 2003, 1638(1), 1-19.
25. Stefan, C.; Jansen, S.; Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem. Sci., 2005, 30, 542-550.
26. Cimpean, A.; Stefan, C.; Gijsbers, R.; Stalmans, W.; Bollen, M. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2. Biochem. J., 2004, 381(1), 71-77.
27. Sakagami, H.; Aoki, J.; Natori, Y.; Nishikawa, K.; Kakehi, Y.; Natori, Y.; Arai, H. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. J. Biol. Chem., 2005, 280, 23084-23093.
28. Laketa, D.; Bjelobaba, I.; Savic, J.; Lavrnja, I.; Stojiljkovic, M.; Rakic, L.; Nedeljkovic, N. Biochemical characterization of soluble nucleotide pyrophosphatase/phosphodiesterase activity in rat serum. Mol. Cell. Biochem., 2010, 339(1-2), 99-106.
29. Harahap, A.R.; Goding, J.W. Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissues. J. Immunol., 1988, 141, 2317-2320.
30. Grobben, B.; Anciaux, K.; Roymans, D.; Stefan, C.; Bollen, M.; Esmans, E.L.; Slegers, H. An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J. Neurochem., 1999, 72(2), 826-834.
31. Aerts, I.; Martin, J.J.; De Deyn, P.P.; Van Ginniken, C.; Van Ostade, X.; Kockx, M.; Dua, G.; Slegers H. The expression of ectonucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade. Clin. Neurol. Neurosurg., 2011, 113(3), 224-229.
32. Tokumura, A.; Majima, E.; Kariya, Y.; Tominaga, K.; Kogure, K.; Yasuda, K.; Fukuzawa, K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem., 2002, 277(42), 39436-3442.
33. Cognato Gde, P.; Czepielewski, R.S.; Sarkis, J.J.; Bogo, M.R.; Bonan C.D. Expression mapping of ectonucleotide pyrophosphatase/phosphodiesterase 1-3 (E-NPP1-3) in different brain structures during rat development. Int. J. Dev. Neurosci., 2008, 26(6), 593-598.
34. Stassar, M.J.; Devitt, G.; Brosius, M.; Rinnab, L.; Prang, J.; Schradin, T.; Simon, J.; Petersen, S.; Kopp-Schneider, A.; Zöller M. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br. J. Cancer, 2001, 85(9), 1372-1382.
35. Hama, K.; Aoki, J.; Fukaya, M.; Kishi, Y.; Sakai, T; Suzuki, R.; Ohta, H.; Yamori, T.; Watanabe, M.; Chun, J.; Arai H. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem., 2004, 279(17), 17634-17639.
36. Kishi, Y.; Okudaira, S.; Tanaka, M.; Hama, K.; Shida, D.; Kitayama, J.; Yamori, T.; Aoki, J.; Fujimaki, T.; Arai, H. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J. Biol. Chem., 2006, 281(25), 17492-17500.
37. Fuss, B.; Baba, H.; Phan, T.; Tuohy, V.K.; Macklin, W.B. Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J. Neurosci., 1997, 17, 9095-9103.
38. Buffon, A.; Casali, E.A.; Cardoso, V.V.; Zerbini, L.F.; Robson, S.C.; Sarkis, J.J.; Wink, M.R. Differential expression of nucleotide pyrophosphatase/phosphodiesterases by Walker 256 mammary cancer cells in solid tumors and malignant ascites. Life Sci., 2010, 86(11-12), 435-440.
39. Blass-Kampmann, S.; Kindler-Röhrborn, A.; Deissler, H.;, D'Urso, D.; Rajewsky, M.F. In vitro differentiation of neural progenitor cells from prenatal rat brain: common cell surface glycoprotein on three glial cell subsets. J. Neurosci. Res., 1997, 48(2), 95-111.
40. Langer, D.; Hammer, K.; Koszalka, P.; Schrader, J.; Robson, S.; Zimmermann, H. Distribution of ectonucleotidases in the rodent brain revisited. Cell Tissue Res., 2008, 334, 199-217.
41. Umemura, K.; Yamashita, N.; Yu, X.; Arima, K.; Asada, T; Makifuchi, T.; Murayama, S.; Saito, Y.; Kanamaru, K.; Goto, Y.; Kohsaka, S.; Kanazawa, I.; Kimura, H. Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci. Lett., 2006, 400(1-2), 97-100.
42. Asensio, A.C.; Rodríguez-Ferrer, C.R.; Castañeyra-Perdomo, A.; Oaknin, S.; Rotllán, P. Biochemical analysis of ecto-nucleotide pyrophosphatase phosphodiesterase activity in brain membranes indicates involvement of NPP1 isoenzyme in extracellular hydrolysis of diadenosine polyphosphates in central nervous system. Neurochem. Int., 2007, 50(4), 581-590.
43. Savaskan, N.E.; Rocha, L.; Kotter, M.R.; Baer, A.; Lubec, G.; van Meeteren, L.A.; Kishi, Y.; Aoki, J.; Moolenaar, W.H.; Nitsch, R.; Braeuer, A.U. Autotaxin (NPP-2) in the brain: Cell type-specific expression and regulation during development and after neurotrauma. Cell. Mol. Life Sci., 2007, 64, 230-243.
44. Albers, H.M.; Dong, A.; van Meeteren, L. A; Egan, D.A.; Sunkara, M., van Tilburg, E.W.; Schuurman, K.; van Tellingen, O.; Morris, A.J.; Smyth, S.S.; Moolenaar, W.H.; Ovaa, H. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc. Natl. Acad. Sci. USA, 2010, 107(16), 7257-7262.
45. Parrill, A. L; Baker, D.L. Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts. Expert Opin. Ther. Pat., 2010, 20(12), 1619-1625.
46. Rücker, B.; Almeida, M.E.; Libermann, T.A.; Zerbini, L.F.; Wink, M.R.; Sarkis, J.J. Biochemical characterization of ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP, E.C. 3.1.4.1) from rat heart left ventricle. Mol. Cell. Biochem., 2007, 306(1-2), 247-254.
47. Munkonda, M.N.; Kauffenstein, G.; Kukulski, F.; Lévesque, S.A.; Legendre, C.; Pelletier, J.; Lavoie, E.G.; Lecka, J.; Sévigny, J. Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochem. Pharmacol., 2007, 74(10), 1524-1534.
48. Khan, K.M.; Fatima, N.; Rasheed, M.; Jalil, S.; Ambreen, N.; Perveen, S.; Choudhary, M.I.1, 3, 4-Oxadiazole-2(3H)-thione and its analogues: A new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors. Bioorg. Med. Chem., 2009, 17, 7816-7822.
49. Choudhary, M.I.; Fatima, N.; Khan, K.M.; Jalil, S.; Iqbal, S.; Attaur-Rahman. New biscoumarin derivatives: Cytotoxicity and enzyme inhibitory activities Bioorg. Med. Chem., 2006, 14, 8066-8072.
50. Eliahu, S.; Lecka, J.; Reiser, G.; Haas, M.; Bigonnesse, F.; Lévesque, S.A.; Pelletier, J.; Sévigny, J.; Fischer, B. Diadenosine 5', 5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors. J. Med. Chem., 2010, 53(24), 8485-8497.
51. Millán, J.L. Alkaline Phosphates: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal., 2006, 2, 335-341.
52. Fonta, C.; Negyessy, L.; Renaud, L; Barone, P. Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex. J. Comp. Neurol., 2005, 486(2), 179-196.
53. Díaz-Hernández, M.; Gómez-Ramos, A.; Rubio, A.; Gómez-Villafuertes, R.; Naranjo, J.R.; Miras-Portugal, M.T.; Avila, J. Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J. Biol. Chem., 2010, 285(42), 32539-32548.
54. Vardy, E.R.; Kellett, K.A.; Cocklin, S.L.; Hooper, N.M. Alkaline phosphatase is increased in both brain and plasma in Alzheimer's disease. Neurodegener. Dis., 2012, 9(1), 31-37.
55. Waymire, K.G.; Mahuren, J.D.; Jaje, J.M.; Guilarte, T.R.; Coburn, S.P.; MacGregor, G.R. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat. Genet., 1995, 11(1), 45-51.
56. Chang, L.; Duy do, L.; Mébarek, S.; Popowycz, F.; Pellet-Rostaing, S.; Lemaire, M.; Buchet, R. Synthesis and evaluation of thiophenyl derivatives as inhibitors of alkaline phosphatase. Bioorg. Med. Chem. Lett., 2011, 21(8), 2297-2301.
57. Dahl, R.; Sergienko, E.A.; Su, Y.; Mostofi, Y. S; Yang, L.;, Simao, A.M.; Narisawa, S.; Brown, B.; Mangravita-Novo, A.; Vicchiarelli, M.; Smith, L.H.; O'Neill, W.C.; Millán, J.L.; Cosford, N.D. Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). J. Med. Chem., 2009, 52(21), 6919-6925.
58. Li, L.; Chang, L.; Pellet-Rostaing, S; Liger, F.; Lemaire, M.; Buchet, R.; Wu, Y. Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases. Bioorg. Med. Chem., 2009, 17(20), 7290-7300.
59. Doengi, M.; Deitmer, J.W.; Lohr, C. New evidence for purinergic signaling in the olfactory bulb: A2A and P2Y1 receptors mediate intracellular calcium release in astrocytes. FASEB J., 2008, 22(7), 2368-2378.
60. Robson, S.C.; Sevigny, J.; Zimmermann, H. The E-NTPDase family of ectonucleotidases: structure function relationship and pathophysiological significance. Purinergic Signal., 2006, 2, 409-430.
61. Knowles, A.F. The GDA1_CD39 superfamily: NTPDases with diverse functions. Purinergic Signal., 2011, 7(1), 21-45.
62. Stout, J.G.; Kirley, T.L. Control of cell membrane ecto-ATPase by oligomerization state: intermolecular cross-linking modulates ATPase activity. Biochemistry, 1996, 35, 8289-8298.
63. Zimmermann, H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol., 2000, 362, 299-309.
64. Smith, T.M.; Kirley, T.L. Site-directed mutagenesis of a human brain ectoapyrase: evidence that the E-type ATPases are related to the actin/heat shock 70/sugar kinase superfamily. Biochemistry, 1999, 38, 321-328.
65. Zimmermann, H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol., 1996, 49, 589-618.
66. Cognato, G.P.; Bruno, A.N.; Vuaden, F.C.; Sarkis, J.J.; Bonan, C.D. Ontogeneic profile of ectonucleotidase activities from brain synaptosomes of pilocarpine-treated rats. Int. J. Dev. Neurosci., 2005, 23(8), 703-709.
67. Cognato, G.P.; Bonan, C.D. Ectonucleotidases and epilepsy. Open Neurosci. J., 2010, 4, 44-52.
68. Bruno, A.N.; Da Silva, R.S.; Bonan, C.D.; Battastini, A.M.; Barreto-Chaves, M.L.; Sarkis, J.J. Hyperthyroidism modifies ectonucleotidase activities in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development. Int. J. Dev. Neurosci., 2003, 21, 401-408.
69. Bruno, A.N.; Ricachenevsky, F.K.; Pochmann, D.; Bonan, C.D.; Battastini, A.M.; Barreto-Chaves, M. L; Sarkis, J.J. Hypothyroidism changes adenine nucleotide hydrolysis in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development. Int. J. Dev. Neurosci., 2005, 23(1), 37-44.
70. Horvat, A.; Stanojevi, I.; Drakuli, D.; Velickovi, N.; Petrovi, S.; Milosevi, M. Effect of acute stress on NTPDase and 5'-nucleotidase activities in brain synaptosomes in different stages of development. Int. J. Dev. Neurosci., 2010, 28(2), 175-182.
71. Bruno, A.N.; Fontella, F.U.; Crema, L.M.; Bonan, C.D.; Dalmaz, C.; Barreto-Chaves, M.L.; Sarkis, J.J. Hyperthyroidism changes nociceptive response and ecto-nucleotidase activities in synaptosomes from spinal cord of rats in different phases of development. Comp. Biochem. Physiol. Part A: Mol. Integr. Physiol., 2005, 140(1), 111-116.
72. Bruno, A.N.; Pochmann, D.; Ricachenevsky, F. K; Fontella, F.U.; Bonan, C.D.; Dalmaz, C.; Barreto-Chaves, M.L.; Sarkis J.J. Nociceptive response and adenine nucleotide hydrolysis in synaptosomes isolated from spinal cord of hypothyroid rats. Neurochem. Res., 2005, 30, 1155-1161.
73. Ivanenkov, V.V.; Meller, J.; Kirley, T.L. Characterization of disulfide bonds in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): implications for NTPDase structural modeling. Biochemistry, 2005, 44(25), 8998-9012.
74. Zimmermann, H.; Braun N. Ecto-nucleotidases: Molecular structures, catalytic properties, and functional roles in the nervous system. Prog. Brain Res., 1999, 120, 371-385.
75. Kukulski, F.; Lévesque, S.A.; Lavoie, E.G.; Lecka, J.; Bigonnesse, F.; Knowles, A.F.; Robson, S.C.; Kirley, T.L., Sévigny, J. Comparative hydrolysis of P2 receptor agonists by NTPDase 1, 2, 3 and 8. Purinergic Signal., 2005, 1, 193-204.
76. Braun, N.; Sévigny, J.; Robson, S.C.; Enjyoji, K.; Guckelberger, O.; Hammer, K.; Di Virgilio, F.; Zimmermann, H. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur. J. Neurosci., 2000, 12(12), 4357-4366.
77. Braun, N.; Sévigny, J.; Mishra, S.K.; Robson, S.C.; Barth, S.W.; Gerstberger, R.; Hammer, K.; Zimmermann, H. Expression of the ecto-ATPase NTPDase2 in the germinal zones of the developing and adult rat brain. Eur. J. Neurosci., 2003, 17(7), 1355-1364.
78. Shukla, V.; Zimmermann, H.; Wang, L.; Kettenmann, H.; Raab, S.; Hammer, K; Sévigny, J.; Robson, S.C.; Braun, N. Functional expression of the ecto-ATPase NTPDase2 and of nucleotide receptors by neuronal progenitor cells in the adult murine hippocampus. J. Neurosci. Res., 2005, 80(5), 600-610.
79. Robson, S.C.; Wu, Y.; Sun, X.F.; Knosalla, C.K.; Dwyer, K.; Enjyoji, K. Ectonucleotidases of CD39 family modulate vascular inflammation m and thrombosis in transplantation. Semin. Thromb. Hemost., 2005, 31, 217-233.
80. Wink, M.R.; Braganhol, E.; Tamajusuku, A.S.; Lenz, G.; Zerbini, L.F.; Libermann, T.A.; Sévigny, J.; Battastini, A.M.; Robson, S.C. Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience, 2006, 138, 421-432.
81. Vorhoff, T.; Zimmermann, H.; Pelletier, J.; Sévigny, J.; Braun N. Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actin. Purinergic Signal., 2005, 1, 259-270.
82. Belcher, S.M.; Zsarnovszky, A.; Crawford, P.A.; Hemani, H.; Spurling, L.; Kirley, T.L. Immunolocalization of ecto-nucleoside triphosphate diphosphohydrolase 3 in rat brain: implications for modulation of multiple homeostatic systems including feeding and sleep-wake behaviors. Neuroscience, 2006, 137(4), 1331-1346.
83. Bigonnesse, F.; Lévesque, S.A.; Kukulski, F.; Lecka, J.; Robson, S.C.; Fernandes, M.J.; Sévigny, J. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry, 2004, 43(18), 5511-5519.
84. Bonan, C.D.; Dias, M.M.; Battastini, A.M.; Dias, R.D.; Sarkis, J.J. Inhibitory avoidance learning inhibits ectonucleotidases activities in hippocampal synaptosomes of adult rats. Neurochem. Res., 1998, 23(7), 977-982.
85. Bonan, C.D.; Roesler, R.; Pereira, G.S.; Battastini, A.M.; Izquierdo, I.; Sarkis J.J. Learning-specific decrease in synaptosomal ATP diphosphohydrolase activity from hippocampus and entorhinal cortex of adult rats. Brain Res., 2000, 854(1-2), 253-256.
86. Pereira, G.S.; Mello e Souza, T.; Battastini, A.M.; Izquierdo, I.; Sarkis, J.J.; Bonan C.D. Effects of inhibitory avoidance training and/or isolated foot-shock on ectonucleotidase activities in synaptosomes of the anterior and posterior cingulate cortex and the medial precentral area of adult rats. Behav. Brain Res., 2002, 128(2), 121-127.
87. Pedrazza, E.L.; Riboldi, G.P.; Pereira, G.S.; Izquierdo, I.; Bonan, C.D. Habituation to an open field alters ecto-nucleotidase activities in rat hippocampal synaptosomes. Neurosci. Lett., 2007, 413(1), 21-24.
88. Oses, J.P.; Batassini, C.; Pochmann, D.; Böhmer, A.E.; Vuaden, F.C.; Silvestrin, R.B.; Oliveira, A.; Bonan, C.D.; Bogo, M.R.; Souza, D.O.; Portela, L.V.; Sarkis, J.J.; Mello e Souza, T. The hydrolysis of striatal adenine-and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease. Neurochem. Res., 2011, 36(2), 215-222.
89. Nagy, A.K.; Walton, N.Y.; Treiman, D.M. Reduced cortical ecto-ATPase activity in rat brains during prolonged status epilepticus induced by sequential administration of lithium and pilocarpine. Mol. Chem. Neuropathol., 1997, 31(2), 135-147.
90. Bonan, C.D.; Walz, R.; Pereira, G.S.; Worm, P.V.; Battastini, A.M.; Cavalheiro, E.A.; Izquierdo, I.; Sarkis, J.J. Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy. Epilepsy Res., 2000, 39(3), 229-238.
91. Bonan, C.D.; Amaral, O.B.; Rockenbach, I.C.; Walz, R.; Battastini, A.M.; Izquierdo, I.; Sarkis, J.J. Altered ATP hydrolysis induced by pentylenetetrazol kindling in rat brain synaptosomes. Neurochem. Res., 2000, 25(6), 775-779.
92. Oses, J.P.; Viola, G.G.; de Paula Cognato, G.; Júnior, V.H.; Hansel, G.; Böhmer, A.E.; Leke, R.; Bruno, A.N.; Bonan, C.D.; Bogo, M.R.; Portela, L.V.; Souza, D.O.; Sarkis, J.J. Pentylenetetrazol kindling alters adenine and guanine nucleotide catabolism in rat hippocampal slices and cerebrospinal fluid. Epilepsy Res., 2007, 75(2-3), 104-111.
93. Siebel, A.M.; Piato, A.L.; Capiotti, K.M.; Seibt, K.J.; Bogo, M.R.; Bonan, C.D. PTZ-induced seizures inhibit adenosine deamination in adult zebrafish brain membranes. Brain Res. Bull., 2011, 86(5-6), 385-289.
94. Cognato, G.P.; Vuaden, F.C.; Savio, L.E.; Bellaver, B.; Casali, E.; Bogo, M.R.; Souza, D.O.; Sévigny, J.; Bonan C.D. Nucleoside triphosphate diphosphohydrolases role in the pathophysiology of cognitive impairment induced by seizure in early age. Neuroscience, 2011, 180, 191-200.
95. Cognato, G. de P; Bruno, A.N.; da Silva, R.S.; Bogo, M.R.; Sarkis, J.J.; Bonan, C.D. Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases. Neurochem. Res., 2007, 32(6), 1046-1055.
96. Siebel, A.M.; Rico, E.P.; Capiotti, K.M.; Piato, A.L.; Cusinato, C.T.; Franco, T.M.; Bogo, M.R.; Bonan, C.D. In vitro effects of antiepileptic drugs on acetylcholinesterase and ectonucleotidase activities in zebrafish (Danio rerio) brain. Toxicol. Invitro, 2010, 24(4), 1279-1284.
97. Horvat, A.; Orli, T.; Banjac, A.; Momi, T.; Petrovi, S.; Demajo, M. Inhibition of rat brain ecto-atpase activity by various drugs. Gen. Physiol. Biophys., 2006, 25(1), 91-105.
98. Knowles, A.F.; Nagy, A.K. Inhibition of an ecto-ATPdiphosphohydrolase by azide. Eur. J. Biochem., 1999, 262(2), 349-357.
99. Gendron, F.P.; Halbfinger, E.; Fischer, B.; Beaudoin, A.R. Inhibitors of NTPDase: key players in the metabolism of extracellular purines. Adv. Exp. Med. Biol., 2000, 486, 119-123.
100. Escalada, A.; Navarro, P.; Ros, E.; Aleu, J.; Solsona, C.; Martín-Satué, M. Gadolinium inhibition of ecto-nucleoside triphosphate diphosphohydrolase activity in Torpedo electric organ. Neurochem. Res., 2004, 29(9), 1711-1714.
101. Müller, C.E.; Iqbal, J.; Baqi, Y.; Zimmermann, H.; Röllich, A.; Stephan, H. Polyoxometalates--a new class of potent ectonucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg. Med. Chem. Lett., 2006, 16(23), 5943-5947.
102. Lévesque, S.A.; Lavoie, E.G.; Lecka, J; Bigonnesse, F.; Sévigny, J. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br. J. Pharmacol., 2007, 152(1), 141-150.
103. Crack, B.E.; Pollard, C.E.; Beukers, M.W.; Roberts, S.M.; Hunt, S.F.; Ingall, A.H.; McKechnie, K.C.; IJzerman, A.P.; Leff, P. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 1995, 114(2), 475-481.
104. Brunschweiger, A.; Iqbal, J.; Umbach, F.; Scheiff, A.B.; Munkonda, M.N.; Sévigny, J.; Knowles, A.F.; Müller, C.E. Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide. J. Med. Chem., 2008, 51(15), 4518-4528.
105. Munkonda, M.N.; Pelletier, J.; Ivanenkov, V.V.; Fausther, M.; Tremblay, A.; Künzli, B.; Kirley, T.L.; Sévigny, J. Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3: partial characterization of the inhibitory epitope and potential applications. FEBS J., 2009, 276(2), 479-496.
106. Coppi, E.; Pugliese, A.M.; Stephan, H.; Müller, C.E.; Pedata, F. Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices. Purinergic Signal., 2007, 3(3), 203-219.
107. Kukulski, F.; Komoszyski, M. Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes. Eur. J. Biochem., 2003, 270(16), 3447-3454.
108. Seibt, K.J.; Oliveira R da, L.; Rico, E.P.; Dias, R.D.; Bogo, M.R.; Bonan, C.D. Antipsychotic drugs inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes. Toxicol. Invitro, 2009, 23(1), 78-82.
109. Pedrazza, E.L.; Rico, E.P.; Senger, M.R.; Pedrazza, L.; Zimmermann, F.F.; Sarkis, J.J.; Bogo, M.R.; Bonan, C.D. Ectonucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline. Eur. J. Pharmacol., 2008, 583(1), 18-25.
110. Barcellos, C.K.; Schetinger, M.R.; Dias, R.D.; Sarkis, J.J. In vitro effect of central nervous system active drugs on the ATPase-ADPase activity and acetylcholinesterase activity from cerebral cortex of adult rats. Gen. Pharmacol., 1998, 31(4), 563-567.
111. Zimmermann, H. 5'-Nucleotidase: molecular structure and functional aspects. Biochem. J., 1992, 285, 345-365.
112. James, S.; Richardson, P.J. Production of adenosine from extracellular ATP at the striatal cholinergic synapse. J. Neurochem., 1993, 60(1), 219-227.
113. Resta, R.; Yamashita, Y.; Thompson, L.F. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol. Rev., 1998, 161, 95-109.
114. Kukulski, F.; Sévigny, J.; Komoszyski, M. Comparative hydrolysis of extracellular adenine nucleotides and adenosine in synaptic membranes from porcine braincortex, hippocampus, cerebellum and medulla oblongata. Brain Res., 2004, 1030(1), 49-56.
115. Schoen, S.W.; Kreutzberg, G.W. 5'-nucleotidase enzyme cytochemistry as a tool for revealing activated glial cells and malleable synapses in CNS development and regeneration. Brain Res. Brain Res. Protoc., 1997, 133-143.
116. Cunha, R.A.; Almeida, T.; Ribeiro, J.A. Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats. J. Neurochem., 2001, 76(2), 372-382.
117. Mackiewicz, M.; Nikonova, E.V.; Zimmermann, J.E.; Romer, M.A.; Cater, J.; Galante, R.J.; Pack, A.I. Age-related changes in adenosine metabolic enzymes in sleep/wake regulatory areas of the brain. Neurobiol. Aging, 2006, 27(2), 351-360.
118. Vianna, E.P.; Ferreira, A.T.; Doná, F.; Cavalheiro, E.A.; da Silva Fernandes, M.J. Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats. Epilepsia, 2005, 46(Suppl 5), 166-173.
119. Schoen, S.W.; Ebert, U.; Löscher, W. 5'-Nucleotidase activity of mossy fibers in the dentate gyrus of normal and epileptic rats. Neuroscience, 1999, 93(2), 519-526.
120. Nedeljkovic, N.; Bjelobaba, I.; Lavrnja, I.; Stojkov, D.; Pekovic, S.; Rakic, L.; Stojiljkovic, M. Early temporal changes in ectonucleotidase activity after cortical stab injury in rat. Neurochem. Res., 2008, 33(5), 873-879.
121. Nedeljkovic, N.; Bjelobaba, I.; Subasic, S.; Lavrnja, I.; Pekovic, S; Stojkov, D.; Vjestica, A.; Rakic, L.; Stojiljkovic, M. Up-regulation of ectonucleotidase activity after cortical stab injury in rats. Cell Biol. Int., 2006, 30(6), 541-546.
122. Bjelobaba, I.; Parabucki, A.; Lavrnja, I.; Stojkov, D.; Dacic, S.; Pekovic, S.; Rakic, L.; Stojiljkovic, M; Nedeljkovic, N. Dynamic changes in the expression pattern of ecto-5'-nucleotidase in the rat model of cortical stab injury. J. Neurosci. Res., 2011, 89(6), 862-873.
123. Cappellari, A.R.; Vasques, G.J.; Bavaresco, L.; Braganhol, E.; Battastini, A.M. Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion. Mol. Cell. Biochem., 2012, 359(1-2), 315-322.
124. Bavaresco, L.; Bernardi, A.; Braganhol, E.; Cappellari, A.R.; Rockenbach, L.; Farias, P.F.; Wink, M.R.; Delgado-Cañedo, A.; Battastini, A.M. The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation. Mol. Cell. Biochem., 2008, 319(1-2), 61-68.
125. Sowa, N.A.; Voss, M.K.; Zylka, M.J. Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation. Mol. Pain, 2010, 6-20.
126. Torres, M.; Pintor, J.; Miras-Portugal, M.T. Presence of ectonucleotidases in cultured chromaffin cells: hydrolysis of extracellular adenine nucleotides. Arch. Biochem. Biophys., 1990, 279(1), 37-44.
127. Baqi, Y.; Lee, S.Y.; Iqbal, J.; Ripphausen, P.; Lehr, A.; Scheiff, A.B.; Zimmermann, H.; Bajorath, J.; Müller, C.E. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. J. Med. Chem., 2010, 53(5), 2076-2086.
128. da Silva, A.C.; Balz, D.; de Souza, J.B.; Morsch, V.M.; Corrêa, M.C.; Zanetti, G.D.; Manfron, M.P.; Schetinger, M.R. Inhibition of NTPDase, 5'-nucleotidase, Na+/K+-ATPase and acetylcholinesterase activities by subchronic treatment with Casearia sylvestris. Phytomedicine, 2006, 13(7), 509-514.
129. Görgen, M.; Turatti, K.; Medeiros, A.R.; Buffon, A.; Bonan, C.D.; Sarkis, J.J.; Pereira, G.S. Aqueous extract of Ilex paraguariensis decreases nucleotide hydrolysis in rat blood serum. J. Ethnopharmacol., 2005, 97(1), 73-77.
130. Braganhol, E.; Tamajusuku, A.S.; Bernardi, A.; Wink, M.R.; Battastini, A.M.; Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line. Biochim. Biophys. Acta, 2007, 1770(9), 1352-1359.
131. King, A.E.; Ackley, M.A.; Cass, C.E.; Young, J.D.; Baldwin, S.A. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol. Sci., 2006, 27(8), 416-425.
132. Parkinson, F.E.; Xiong, W.; Zamzow, C.R. Astrocytes and neurons: different roles in regulating adenosine levels. Neurol. Res., 2005, 27(2), 153-160.
133. Ipata, P.L.; Camici, M.; Micheli, V.; Tozz, M.G. Metabolic network of nucleosides in the brain. Curr. Top Med. Chem., 2011, 11(8), 909-922.
134. Spector, R.; Johanson, C.E. The origin of deoxynucleosides in brain: implications for the study of neurogenesis and stem cell therapy. Pharm. Res., 2007, 24, 859-867.
135. Yao, S.Y.; Ng, A.M.; Cass, C.E.; Baldwin, S.A.; Young, J.D. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1). J. Biol. Chem., 2011, 286(37), 32552-32562.
136. Yao, S.Y.; Ng, A.M.; Vickers, M.F.; Sundaram, M.; Cass, C.E.; Baldwin, S.A.; Young, J.D. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J. Biol. Chem., 2002, 277(28), 24938-24948.
137. Parkinson, F.E.; Damaraju, V.L.; Graham, K.; Yao, S.Y.; Baldwin, S.A.; Cass, C.E.; Young, J.D. Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr. Top Med. Chem., 2011, 11(8), 948-972.
138. Choi, D.S.; Cascini, M.G.; Mailliard, W.; Young, H.; Paredes, P.; McMahon, T.; Diamond, I.; Bonci, A.; Messing, R.O. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat. Neurosci., 2004, 7(8), 855-861.
139. Kost, S.; Sun, C.; Xiong, W.; Graham, K.; Cass, C.E.; Young, J.D.; Albensi, B.C.; Parkinson, F.E. Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice. Behav. Brain Res., 2011, 224(1), 44-49.
140. Chen, J.; Rinaldo, L.; Lim, S.J.; Young, H.; Messing, R.O.; Choi, D.S. The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice. Genes Brain Behav., 2007, 6(8), 776-783.
141. Zhang, D.; Xiong, W.; Albensi, B.C.; Parkinson, F.E. Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. J. Neurochem., 2011, 118(1), 4-11.
142. Shan, D.; Haroutunian, V; Meador-Woodruff, J.H.; McCullumsmith, R.E. Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia. Neuroreport, 2012, 23(4), 224-227.
143. Saravanan, K.; Barlow, H.C.; Barton, M.; Calvert, A.H.; Golding, B.T.; Newell, D.R.; Northen, J.S.; Curtin, N.J.; Thomas, H.D.; Griffin, R.J. Nucleoside transport inhibitors: structure-activity relationships for pyrimido[5, 4-d]pyrimidine derivatives that potentiate pemetrexed cytotoxicity in the presence of 1-acid glycoprotein. J. Med. Chem., 2011, 54(6), 1847-1859.
144. Huang, N.K.; Lin, J.H.; Lin, J.T.; Lin, C.I.; Liu, E.M.; Lin, C.J.; Chen, W.P.; Shen, Y.C.; Chen, H.M.; Chen, J.B.; Lai, H.L.; Yang, C.W.; Chiang, M.C.; Wu, Y.S.; Chang, C.; Chen, J.F.; Fang, J. M; Lin, Y.L.; Chern, Y. A new drug design targeting the adenosinergic system for Huntington'sdisease. PLoS One, 2011, 6(6), e20934.
145. Smith, K.M.; Slugoski, M.D.; Loewen, S.K.; Ng, A.M.; Yao, S.Y.; Chen, X.Z.; Karpinski, E.; Cass, C.E.; Baldwin, S.A.; Young, J.D. The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics. J. Biol. Chem., 2005, 280(27), 25436-25449.
146. Gray, J.H.; Owen, R.P.; Giacomini, K.M. The concentrative nucleoside transporter family, SLC28. Pflugers Arch., 2004, 447, 728-734.
147. Melani, A.; Corti, F.; Stephan, H.; Müller, C.E.; Donati, C.; Bruni, P.; Vannucchi, M.G.; Pedata, F. Ecto-ATPase inhibition: ATP and adenosine release under physiologicaland ischemic in vivo conditions in the rat striatum. Exp. Neurol., 2012, 233(1), 193-204.
148. Guillén-Gómez, E.; Calbet, M.; Casado, J.; de Lecea, L.; Soriano, E.; Pastor-Anglada, M.; Burgaya, F. Distribution of CNT2 and ENT1 transcripts in rat brain: selective decrease of CNT2 mRNA in the cerebral cortex of sleep-deprived rats. J. Neurochem., 2004, 90(4), 883-893.